VSIR and endometrial cancer: A retrospective analysis showed that VISTA expression was present in all endometrial cancer specimens under regulating promoter methylation status and that VISTA expressing in TCs inhibited CTLs against antigen-specific cytolysis and significantly suppressed T cell proliferation.